테스토스테론 보충 요법 시장 규모, 점유율 및 동향 분석 보고서 - 최종 사용자별, 제품 유형별, 활성 및 지역별 전망 및 예측(2024-2031년)

The Global Testosterone Replacement Therapy Market size is expected to reach $2.5 billion by 2031, rising at a market growth of 4.1% CAGR during the forecast period.

Testosterone enanthate has been widely used and studied for TRT, demonstrating consistent effectiveness in restoring testosterone levels to within the normal physiological range and improving symptoms of hypogonadism. Consequently, the testosterone enanthate segment would generate approximately 19.3% revenue share of the market by 2031. Clinical trials and real-world experience have shown that testosterone enanthate therapy effectively improves libido, erectile function, muscle mass, bone density, mood, energy levels, and overall quality of life in individuals with testosterone deficiency.

Men's testosterone levels naturally decrease with age, this condition is referred to as andropause or late-onset hypogonadism. Usually starting around the age of 30, this deterioration steadily gets worse over time. By the age of 40 or 50, many men may experience symptoms of low testosterone, such as reduced libido, fatigue, decreased muscle mass, and mood changes. Thus, the growing elderly population worldwide is driving the growth of the market.

Additionally, as healthcare expenditure rises, more individuals gain access to healthcare services, including preventive care, diagnostic testing, and specialized treatments. This expanded access enables more men to seek medical advice and treatment for conditions such as hypogonadism, leading to increased demand for TRT. With greater healthcare spending, there is increased investment in diagnostic technologies, screening programs, and healthcare infrastructure. In conclusion, the rising expenditure in the healthcare sector is driving the growth of the market.

However, TRT can be expensive, particularly for long-term treatment. The cost of TRT includes not only the price of testosterone medications but also expenses related to doctor visits, laboratory tests, monitoring, and follow-up appointments. The substantial expense of TRT may present a major obstacle to access for those lacking sufficient health insurance or financial means, restricting their capacity to begin or continue therapy. In conclusion, the high cost of testosterone replacement therapy is hindering the growth of the market.

The market relies on a complex global supply chain for raw materials, manufacturing, and distribution. Disruptions in the supply chain, including factory closures, transportation restrictions, and labor shortages, led to delays in product manufacturing and shortages of TRT medications in some regions. Thus, the COVID-19 pandemic had a negative impact on the growth of the market.

By End User Analysis

By end user, the market is divided into hospital and clinics. The clinics segment attained 66.6% revenue share in the market in 2023. Clinics offer convenient access to healthcare services for individuals seeking diagnosis and treatment for hormone-related conditions such as hypogonadism. Also, clinics are often located in community settings and urban areas, making them easily accessible to patients who may not have access to hospital-based care.

By Product Type Analysis

Based on product type, the market is divided into injectables, topical, and others. The topical segment attained a 19.7% revenue share in the market in 2023. Topical testosterone formulations, such as gels and creams, offer patients more convenience and ease of use than injectable or implantable options. They are typically applied to the skin once daily, allowing for self-administration at home without the need for healthcare provider visits or invasive procedures. This convenience appeals to patients seeking a noninvasive and discreet treatment option for hypogonadism.

By Active Ingredient Analysis

On the basis of active ingredients, the market is segmented into testosterone undecanoate, testosterone cypionate, testosterone, testosterone enanthate, and others. The testosterone cypionate segment recorded 32.65% revenue share in the market in 2023. Testosterone cypionate has a longer half-life and a slower rate of release since it is a long-acting ester of testosterone. This characteristic allows for less frequent dosing, typically every one to two weeks, making it convenient for patients and reducing the burden of frequent injections.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe region generated a 29.18% revenue share in the market in 2023. There is a growing awareness of hypogonadism and testosterone deficiency among healthcare providers and patients in Europe. Healthcare professionals are increasingly proactive in screening for and diagnosing testosterone deficiency, leading to earlier detection and treatment initiation. Additionally, educational campaigns and increased access to information contribute to heightened awareness and demand for TRT among patients.

Recent Strategies Deployed in the Market

• Sep-2023: Besins Healthcare Monaco S.A.M. expanded its footprints by inaugurating a novel hormone production facility in Muel, situated near Zaragoza, Spain. Through this expansion, Besins Healthcare strengthened its commitment to expand its production capacity in Europe, boosting it by 30%. Additionally, with expansion, the company aims to meet the demand for hormonal replacement therapies (HRT).
• Sep-2022: Marius Pharmaceuticals LLC received approval from the U.S. Food and Drug Administration (FDA) for KYZATREX, an oral testosterone replacement therapy. KYZATREX is used for the treatment of conditions associated with a deficiency or absence of endogenous testosterone in adult males. Additionally, KYZATREX is approved for use in three dosage strengths: 100mg, 150mg, and 200mg.
• Mar-2022: Pfizer, Inc. completed the acquisition of Arena Pharmaceuticals, Inc., an American biopharmaceutical company. Through this acquisition, Pfizer gained access to Arena's suite of various treatment candidates developed for gastroenterology, dermatology, and cardiology areas. Additionally, Pfizer received rights to Arena's oral, selective sphingosine 1-phosphate (S1P) receptor modulator, etrasimod, developed for a variety of immuno-inflammatory ailments.
• Feb-2022: Eli Lilly and Company signed a clinical trial collaboration and supply agreement with Veru Inc., an oncology biopharmaceutical company. Under this collaboration, the companies would evaluate the efficacy and safety of enobosarm, Veru's oral, chemical entity, selective androgen receptor targeting agonist that activates the androgen receptor (AR), a tumor suppressor, in combination with Lilly's Verzenio (abemaciclib), a CDK4/6 inhibitor, as a second-line therapy in the treatment of AR+ER+HER2-metastatic breast cancer.

List of Key Companies Profiled

• Endo International PLC
• AbbVie, Inc.
• Pfizer, Inc.
• Eli Lilly And Company
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals, Inc.
• Ferring Holdings SA
• Marius Pharmaceuticals LLC
• Besins Healthcare Monaco S.A.M.
• Acrux Limited

Global Testosterone Replacement Therapy Market Report Segmentation

By End User

• Clinics
• Hospital

By Product Type

• Injectables
• Topical
• Others

By Active ingredient

• Testosterone Cypionate
• Testosterone Undecanoate
• Testosterone Enanthate
• Testosterone
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Testosterone Replacement Therapy Market, by End User
  • 1.4.2Global Testosterone Replacement Therapy Market, by Product Type
  • 1.4.3Global Testosterone Replacement Therapy Market, by Active ingredient
  • 1.4.4Global Testosterone Replacement Therapy Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global Testosterone Replacement Therapy Market by End User

• 4.1Global Clinics Market by Region
• 4.2Global Hospital Market by Region

Chapter 5.Global Testosterone Replacement Therapy Market by Product Type

• 5.1Global Injectables Market by Region
• 5.2Global Topical Market by Region
• 5.3Global Others Market by Region

Chapter 6.Global Testosterone Replacement Therapy Market by Active ingredients

• 6.1Global Testosterone Cypionate Market by Region
• 6.2Global Testosterone Undecanoate Market by Region
• 6.3Global Testosterone Enanthate Market by Region
• 6.4Global Testosterone Market by Region
• 6.5Global Others Market by Region

Chapter 7.Global Testosterone Replacement Therapy Market by Region

• 7.1North America Testosterone Replacement Therapy Market
  • 7.1.1North America Testosterone Replacement Therapy Market by End User
    • 7.1.1.1North America Clinics Market by Region
    • 7.1.1.2North America Hospital Market by Region
  • 7.1.2North America Testosterone Replacement Therapy Market by Product Type
    • 7.1.2.1North America Injectables Market by Country
    • 7.1.2.2North America Topical Market by Country
    • 7.1.2.3North America Others Market by Country
  • 7.1.3North America Testosterone Replacement Therapy Market by Active ingredients
    • 7.1.3.1North America Testosterone Cypionate Market by Country
    • 7.1.3.2North America Testosterone Undecanoate Market by Country
    • 7.1.3.3North America Testosterone Enanthate Market by Country
    • 7.1.3.4North America Testosterone Market by Country
    • 7.1.3.5North America Others Market by Country
  • 7.1.4North America Testosterone Replacement Therapy Market by Country
    • 7.1.4.1US Testosterone Replacement Therapy Market
      • 7.1.4.1.1US Testosterone Replacement Therapy Market by End User
      • 7.1.4.1.2US Testosterone Replacement Therapy Market by Product Type
      • 7.1.4.1.3US Testosterone Replacement Therapy Market by Active ingredients
    • 7.1.4.2Canada Testosterone Replacement Therapy Market
      • 7.1.4.2.1Canada Testosterone Replacement Therapy Market by End User
      • 7.1.4.2.2Canada Testosterone Replacement Therapy Market by Product Type
      • 7.1.4.2.3Canada Testosterone Replacement Therapy Market by Active ingredients
    • 7.1.4.3Mexico Testosterone Replacement Therapy Market
      • 7.1.4.3.1Mexico Testosterone Replacement Therapy Market by End User
      • 7.1.4.3.2Mexico Testosterone Replacement Therapy Market by Product Type
      • 7.1.4.3.3Mexico Testosterone Replacement Therapy Market by Active ingredients
    • 7.1.4.4Rest of North America Testosterone Replacement Therapy Market
      • 7.1.4.4.1Rest of North America Testosterone Replacement Therapy Market by End User
      • 7.1.4.4.2Rest of North America Testosterone Replacement Therapy Market by Product Type
      • 7.1.4.4.3Rest of North America Testosterone Replacement Therapy Market by Active ingredients
• 7.2Europe Testosterone Replacement Therapy Market
  • 7.2.1Europe Testosterone Replacement Therapy Market by End User
    • 7.2.1.1Europe Clinics Market by Country
    • 7.2.1.2Europe Hospital Market by Country
  • 7.2.2Europe Testosterone Replacement Therapy Market by Product Type
    • 7.2.2.1Europe Injectables Market by Country
    • 7.2.2.2Europe Topical Market by Country
    • 7.2.2.3Europe Others Market by Country
  • 7.2.3Europe Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.3.1Europe Testosterone Cypionate Market by Country
    • 7.2.3.2Europe Testosterone Undecanoate Market by Country
    • 7.2.3.3Europe Testosterone Enanthate Market by Country
    • 7.2.3.4Europe Testosterone Market by Country
    • 7.2.3.5Europe Others Market by Country
  • 7.2.4Europe Testosterone Replacement Therapy Market by Country
    • 7.2.4.1Germany Testosterone Replacement Therapy Market
      • 7.2.4.1.1Germany Testosterone Replacement Therapy Market by End User
      • 7.2.4.1.2Germany Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.1.3Germany Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.2UK Testosterone Replacement Therapy Market
      • 7.2.4.2.1UK Testosterone Replacement Therapy Market by End User
      • 7.2.4.2.2UK Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.2.3UK Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.3France Testosterone Replacement Therapy Market
      • 7.2.4.3.1France Testosterone Replacement Therapy Market by End User
      • 7.2.4.3.2France Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.3.3France Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.4Russia Testosterone Replacement Therapy Market
      • 7.2.4.4.1Russia Testosterone Replacement Therapy Market by End User
      • 7.2.4.4.2Russia Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.4.3Russia Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.5Spain Testosterone Replacement Therapy Market
      • 7.2.4.5.1Spain Testosterone Replacement Therapy Market by End User
      • 7.2.4.5.2Spain Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.5.3Spain Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.6Italy Testosterone Replacement Therapy Market
      • 7.2.4.6.1Italy Testosterone Replacement Therapy Market by End User
      • 7.2.4.6.2Italy Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.6.3Italy Testosterone Replacement Therapy Market by Active ingredients
    • 7.2.4.7Rest of Europe Testosterone Replacement Therapy Market
      • 7.2.4.7.1Rest of Europe Testosterone Replacement Therapy Market by End User
      • 7.2.4.7.2Rest of Europe Testosterone Replacement Therapy Market by Product Type
      • 7.2.4.7.3Rest of Europe Testosterone Replacement Therapy Market by Active ingredients
• 7.3Asia Pacific Testosterone Replacement Therapy Market
  • 7.3.1Asia Pacific Testosterone Replacement Therapy Market by End User
    • 7.3.1.1Asia Pacific Clinics Market by Country
    • 7.3.1.2Asia Pacific Hospital Market by Country
  • 7.3.2Asia Pacific Testosterone Replacement Therapy Market by Product Type
    • 7.3.2.1Asia Pacific Injectables Market by Country
    • 7.3.2.2Asia Pacific Topical Market by Country
    • 7.3.2.3Asia Pacific Others Market by Country
  • 7.3.3Asia Pacific Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.3.1Asia Pacific Testosterone Cypionate Market by Country
    • 7.3.3.2Asia Pacific Testosterone Undecanoate Market by Country
    • 7.3.3.3Asia Pacific Testosterone Enanthate Market by Country
    • 7.3.3.4Asia Pacific Testosterone Market by Country
    • 7.3.3.5Asia Pacific Others Market by Country
  • 7.3.4Asia Pacific Testosterone Replacement Therapy Market by Country
    • 7.3.4.1China Testosterone Replacement Therapy Market
      • 7.3.4.1.1China Testosterone Replacement Therapy Market by End User
      • 7.3.4.1.2China Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.1.3China Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.2Japan Testosterone Replacement Therapy Market
      • 7.3.4.2.1Japan Testosterone Replacement Therapy Market by End User
      • 7.3.4.2.2Japan Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.2.3Japan Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.3India Testosterone Replacement Therapy Market
      • 7.3.4.3.1India Testosterone Replacement Therapy Market by End User
      • 7.3.4.3.2India Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.3.3India Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.4South Korea Testosterone Replacement Therapy Market
      • 7.3.4.4.1South Korea Testosterone Replacement Therapy Market by End User
      • 7.3.4.4.2South Korea Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.4.3South Korea Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.5Singapore Testosterone Replacement Therapy Market
      • 7.3.4.5.1Singapore Testosterone Replacement Therapy Market by End User
      • 7.3.4.5.2Singapore Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.5.3Singapore Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.6Australia Testosterone Replacement Therapy Market
      • 7.3.4.6.1Australia Testosterone Replacement Therapy Market by End User
      • 7.3.4.6.2Australia Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.6.3Australia Testosterone Replacement Therapy Market by Active ingredients
    • 7.3.4.7Rest of Asia Pacific Testosterone Replacement Therapy Market
      • 7.3.4.7.1Rest of Asia Pacific Testosterone Replacement Therapy Market by End User
      • 7.3.4.7.2Rest of Asia Pacific Testosterone Replacement Therapy Market by Product Type
      • 7.3.4.7.3Rest of Asia Pacific Testosterone Replacement Therapy Market by Active ingredients
• 7.4LAMEA Testosterone Replacement Therapy Market
  • 7.4.1LAMEA Testosterone Replacement Therapy Market by End User
    • 7.4.1.1LAMEA Clinics Market by Country
    • 7.4.1.2LAMEA Hospital Market by Country
  • 7.4.2LAMEA Testosterone Replacement Therapy Market by Product Type
    • 7.4.2.1LAMEA Injectables Market by Country
    • 7.4.2.2LAMEA Topical Market by Country
    • 7.4.2.3LAMEA Others Market by Country
  • 7.4.3LAMEA Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.3.1LAMEA Testosterone Cypionate Market by Country
    • 7.4.3.2LAMEA Testosterone Undecanoate Market by Country
    • 7.4.3.3LAMEA Testosterone Enanthate Market by Country
    • 7.4.3.4LAMEA Testosterone Market by Country
    • 7.4.3.5LAMEA Others Market by Country
  • 7.4.4LAMEA Testosterone Replacement Therapy Market by Country
    • 7.4.4.1Brazil Testosterone Replacement Therapy Market
      • 7.4.4.1.1Brazil Testosterone Replacement Therapy Market by End User
      • 7.4.4.1.2Brazil Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.1.3Brazil Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.2Argentina Testosterone Replacement Therapy Market
      • 7.4.4.2.1Argentina Testosterone Replacement Therapy Market by End User
      • 7.4.4.2.2Argentina Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.2.3Argentina Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.3UAE Testosterone Replacement Therapy Market
      • 7.4.4.3.1UAE Testosterone Replacement Therapy Market by End User
      • 7.4.4.3.2UAE Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.3.3UAE Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.4Saudi Arabia Testosterone Replacement Therapy Market
      • 7.4.4.4.1Saudi Arabia Testosterone Replacement Therapy Market by End User
      • 7.4.4.4.2Saudi Arabia Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.4.3Saudi Arabia Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.5South Africa Testosterone Replacement Therapy Market
      • 7.4.4.5.1South Africa Testosterone Replacement Therapy Market by End User
      • 7.4.4.5.2South Africa Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.5.3South Africa Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.6Nigeria Testosterone Replacement Therapy Market
      • 7.4.4.6.1Nigeria Testosterone Replacement Therapy Market by End User
      • 7.4.4.6.2Nigeria Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.6.3Nigeria Testosterone Replacement Therapy Market by Active ingredients
    • 7.4.4.7Rest of LAMEA Testosterone Replacement Therapy Market
      • 7.4.4.7.1Rest of LAMEA Testosterone Replacement Therapy Market by End User
      • 7.4.4.7.2Rest of LAMEA Testosterone Replacement Therapy Market by Product Type
      • 7.4.4.7.3Rest of LAMEA Testosterone Replacement Therapy Market by Active ingredients

Chapter 8.Company Profiles

• 8.1Endo International PLC
  • 8.1.1Company Overview
  • 8.1.2Financial Analysis
  • 8.1.3Segmental Analysis
  • 8.1.4Research & Development Expense
  • 8.1.5SWOT Analysis
• 8.2AbbVie, Inc.
  • 8.2.1Company Overview
  • 8.2.2Financial Analysis
  • 8.2.3Regional Analysis
  • 8.2.4Research & Development Expense
  • 8.2.5SWOT Analysis
• 8.3Pfizer, Inc.
  • 8.3.1Company Overview
  • 8.3.2Financial Analysis
  • 8.3.3Regional & Segmental Analysis
  • 8.3.4Research & Development Expense
  • 8.3.5Recent strategies and developments:
    • 8.3.5.1Acquisition and Mergers:
  • 8.3.6SWOT Analysis
• 8.4Eli Lilly And Company
  • 8.4.1Company Overview
  • 8.4.2Financial Analysis
  • 8.4.3Regional Analysis
  • 8.4.4Research & Development Expenses
  • 8.4.5Recent strategies and developments:
    • 8.4.5.1Partnerships, Collaborations, and Agreements:
  • 8.4.6SWOT Analysis
• 8.5Teva Pharmaceutical Industries Ltd.
  • 8.5.1Company Overview
  • 8.5.2Financial Analysis
  • 8.5.3Regional Analysis
  • 8.5.4Research & Development Expenses
  • 8.5.5SWOT Analysis
• 8.6Amneal Pharmaceuticals, Inc.
  • 8.6.1Company Overview
  • 8.6.2Financial Analysis
  • 8.6.3Segmental Analysis
  • 8.6.4Research & Development Expenses
  • 8.6.5SWOT Analysis
• 8.7Ferring Holdings SA
  • 8.7.1Company Overview
  • 8.7.2Financial Analysis
  • 8.7.3Regional Analysis
  • 8.7.4Research and Development Expense
  • 8.7.5SWOT Analysis
• 8.8Marius Pharmaceuticals LLC
  • 8.8.1Company Overview
  • 8.8.2Recent strategies and developments:
    • 8.8.2.1Trials & Approvals:
• 8.9Besins Healthcare Monaco S.A.M.
  • 8.9.1Company Overview
  • 8.9.2Recent strategies and developments:
    • 8.9.2.1Geographical Expansions:
• 8.10.Acrux Limited
  • 8.10.1Company Overview
  • 8.10.2Financial Analysis
  • 8.10.3Regional Analysis
  • 8.10.4Research & Development Expenses
  • 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of Testosterone Replacement Therapy Market